Aprecia Pharmaceuticals, the company behind the first and only FDA approved 3D printed drug Spritam, has entered into an agreement with Cycle Pharmaceuticals Ltd. based in Cambridge, UK. The companies will work together using Aprecia’s binder jet 3D printing to produce orphan drugs for treatment of rare medical conditions. The benefits of 3D printed drugs Aprecia’s […]
from 3D Printing Industry
miércoles, 13 de diciembre de 2017
4:20
MR: EDITOR
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation.
Related Posts